FDA allows marketing of non-invasive device to help evaluate heart blood flow
The FDA allowed marketing of the HeartFlow FFR-CT software, which permits health care professionals to non-invasively evaluate blood flow in the coronary arteries of patients showing signs and symptoms of coronary artery disease. November 26, 2014